These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9415568

  • 1. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation.
    Patrassi GM, Sartori MT, Livi U, Casonato A, Danesin C, Vettore S, Girolami A.
    Transplantation; 1997 Dec 15; 64(11):1610-4. PubMed ID: 9415568
    [Abstract] [Full Text] [Related]

  • 2. Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
    Sartori TM, Maurizio PG, Sara P, Ugolino L, Annalisa A, Panagiotis T, Massimo F, Antonio G.
    J Heart Lung Transplant; 1999 Jul 15; 18(7):693-700. PubMed ID: 10452346
    [Abstract] [Full Text] [Related]

  • 3. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT, Rigotti P, Marchini F, Spiezia L, Baldan N, Furian L, Varvarikis C, Girolami A.
    Transplantation; 2003 Apr 15; 75(7):994-8. PubMed ID: 12698086
    [Abstract] [Full Text] [Related]

  • 4. Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients.
    Sartori MT, Patrassi GM, Rigotti P, Marchini F, Fioretti M, Spiezia L, Girolami A.
    Transplantation; 2000 May 27; 69(10):2116-21. PubMed ID: 10852608
    [Abstract] [Full Text] [Related]

  • 5. Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment.
    Patrassi GM, Sartori MT, Rigotti P, Di Landro D, Theodoridis P, Fioretti M, Capalbo M, Saggiorato G, Boeri G, Girolami A.
    Transplantation; 1995 May 27; 59(10):1416-20. PubMed ID: 7770928
    [Abstract] [Full Text] [Related]

  • 6. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
    Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A.
    Blood Coagul Fibrinolysis; 1992 Dec 27; 3(6):789-93. PubMed ID: 1489900
    [Abstract] [Full Text] [Related]

  • 7. The effect of cyclosporine on regulators of fibrinolysis in plasma from renal allograft recipients.
    Elhasade AS, Perkowska A, Paczek L, Rowiński W, Soluch L, Szmidt J, Gałazka Z, Gaciong Z.
    Ann Transplant; 1998 Dec 27; 3(1):13-8. PubMed ID: 9869892
    [Abstract] [Full Text] [Related]

  • 8. Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with cyclosporine and prednisone.
    Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M.
    Transplant Proc; 2003 Dec 27; 35(8):2940-2. PubMed ID: 14697944
    [Abstract] [Full Text] [Related]

  • 9. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients.
    Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M.
    Transplantation; 1996 Sep 27; 62(6):828-30. PubMed ID: 8824484
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
    van den Dorpel MA, Veld AJ, Levi M, ten Cate JW, Weimar W.
    Arterioscler Thromb Vasc Biol; 1999 Jun 27; 19(6):1555-8. PubMed ID: 10364089
    [Abstract] [Full Text] [Related]

  • 11. Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil.
    Levi M, Wilmink J, Büller HR, Surachno J, ten Cate JW.
    Transplantation; 1992 Dec 27; 54(6):978-83. PubMed ID: 1465791
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
    van den Dorpel MA, Levi M, IJzermans JN, ten Cate JW, Weimar W.
    Transplant Proc; 1999 Dec 27; 31(1-2):329. PubMed ID: 10083130
    [No Abstract] [Full Text] [Related]

  • 13. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K, Vít L, Opatrná S, Sulková S, Bodláková B.
    Cas Lek Cesk; 1994 May 30; 133(11):346-9. PubMed ID: 8004664
    [Abstract] [Full Text] [Related]

  • 14. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 30; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 15. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
    Perkowska A, Elhasade A, Durlik M, Placha G, Gałazka Z, Lao M, Gaciong Z.
    Ann Transplant; 2002 Dec 30; 7(1):44-51. PubMed ID: 12221903
    [Abstract] [Full Text] [Related]

  • 16. Fibrinolysis in chronic renal failure, dialysis and renal transplantation.
    Opatrný K, Zemanová P, Opatrná S, Vít L.
    Ann Transplant; 2002 Dec 30; 7(1):34-43. PubMed ID: 12221902
    [Abstract] [Full Text] [Related]

  • 17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients.
    Verpooten GA, Cools FJ, Van der Planken MG, Bedert LC, Claes R, Van Gaal LF, De Broe ME.
    Nephrol Dial Transplant; 1996 Feb 22; 11(2):347-51. PubMed ID: 8671791
    [Abstract] [Full Text] [Related]

  • 19. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 22; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 20. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Shahar E, Folsom AR, Salomaa VV, Stinson VL, McGovern PG, Shimakawa T, Chambless LE, Wu KK.
    Circulation; 1996 Jun 01; 93(11):1970-5. PubMed ID: 8640970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.